These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 25227287

  • 1. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
    Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y.
    J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
    [Abstract] [Full Text] [Related]

  • 2. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
    van de Laarschot DM, McKenna MJ, Abrahamsen B, Langdahl B, Cohen-Solal M, Guañabens N, Eastell R, Ralston SH, Zillikens MC.
    J Clin Endocrinol Metab; 2020 May 01; 105(5):1682-99. PubMed ID: 31867670
    [Abstract] [Full Text] [Related]

  • 3. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
    Tsuchie H, Miyakoshi N, Iba K, Kasukawa Y, Nozaka K, Dohke T, Kosukegawa I, Aizawa T, Maekawa S, Abe H, Takeshima M, Tomite T, Segawa T, Ouchi K, Kinoshita H, Suzuki M, Yamashita T, Shimada Y.
    Osteoporos Int; 2018 Dec 01; 29(12):2659-2665. PubMed ID: 30105400
    [Abstract] [Full Text] [Related]

  • 4. The effect of teriparatide on fracture healing after atypical femoral fracture: A systematic review and meta-analysis.
    Byun SE, Lee KJ, Shin WC, Moon NH, Kim CH.
    Osteoporos Int; 2023 Aug 01; 34(8):1323-1334. PubMed ID: 37095179
    [Abstract] [Full Text] [Related]

  • 5. The effect of teriparatide on patients with atypical femur fractures: a systematic review and meta-analysis.
    Salamah HM, Abualkhair KA, Kamal SK, Mohamed HA, Alkheder A, Farho MA, Mistry D, Elbardesy H.
    Arch Orthop Trauma Surg; 2024 Mar 01; 144(3):1091-1106. PubMed ID: 38135789
    [Abstract] [Full Text] [Related]

  • 6. Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
    Zhang HY, Weng HL, Li M, Zhang J.
    Osteoporos Int; 2019 Nov 01; 30(11):2349-2354. PubMed ID: 31428823
    [Abstract] [Full Text] [Related]

  • 7. Medication management after intramedullary nailing of atypical fractures.
    Feron JM, Cambon-Binder A.
    Injury; 2017 Jun 01; 48 Suppl 1():S15-S17. PubMed ID: 28456365
    [Abstract] [Full Text] [Related]

  • 8. A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation.
    Shin WC, Moon NH, Jang JH, Seo HU, Suh KT.
    Bone; 2019 Nov 01; 128():115033. PubMed ID: 31398503
    [Abstract] [Full Text] [Related]

  • 9. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Greenspan SL, Vujevich K, Britton C, Herradura A, Gruen G, Tarkin I, Siska P, Hamlin B, Perera S.
    Osteoporos Int; 2018 Feb 01; 29(2):501-506. PubMed ID: 29085957
    [Abstract] [Full Text] [Related]

  • 10. Teriparatide Does not Have Beneficial Effects on Bone Healing in Complete Atypical Femur Fractures.
    Song G, Jeong Y, Nam WD, Kim KH.
    Calcif Tissue Int; 2024 Aug 01; 115(2):169-173. PubMed ID: 38907093
    [Abstract] [Full Text] [Related]

  • 11. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL, Su CY, Chang CW, Chen CH, Fu TS, Chen LH, Lin TY.
    BMC Musculoskelet Disord; 2017 Dec 13; 18(1):527. PubMed ID: 29237448
    [Abstract] [Full Text] [Related]

  • 12. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
    Starr J, Tay YKD, Shane E.
    Curr Osteoporos Rep; 2018 Aug 13; 16(4):519-529. PubMed ID: 29951870
    [Abstract] [Full Text] [Related]

  • 13. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
    Lim HS, Kim CK, Park YS, Moon YW, Lim SJ, Kim SM.
    J Bone Joint Surg Am; 2016 Dec 07; 98(23):1978-1987. PubMed ID: 27926679
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease.
    Lai KH, Chiang CY, Yang RS, Yang KC, Wu CC.
    Acta Clin Belg; 2019 Oct 07; 74(5):370-374. PubMed ID: 30336748
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.